Comparative safety of interleukin inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis of randomized controlled trials
BackgroundThe safety of biological agents in the treatment of rheumatoid arthritis (RA) is an important factor affecting patient prognosis and treatment adherence. Among them, interleukin inhibitors are an important category. However, the safety of dif…